AKTX
Akari Therapeutics
AKTX
AKTX
21 hedge funds and large institutions have $16.8M invested in Akari Therapeutics in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+8
Holders Change %
+61.54%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$2.96M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.29M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$871K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$866K |
| 5 |
Millennium Management
New York
|
+$626K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$796K |
| 2 |
Morgan Stanley
New York
|
-$39K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.53K |
